Abstract
Plant proteins have been drawing increasing attention owing to their safety, abundance and relatively low cost in comparison with animal proteins. The development of plant protein-based delivery vehicles may lead to the provision of novel pharmaceutical products to patients. Zein is a class of alcohol-soluble prolamine proteins present in maize endosperm that was approved as a generally recognised as safe excipient in 1985 by the US FDA for use in pharmaceutical film coatings. Over the past few decades, numerous studies have been carried out to illustrate zein’s potential for novel applications in the biomedical field. This paper reviews the present status of zein-based nanofibres, with emphasis on their fabrication and biomedical applications, particularly for drug delivery. Their benefits and limitations are also discussed to provide further insight into zein’s potential as a promising biomaterial.
Keywords: Biocompatibility, biomedical application, biopolymer, immunogenicity, zein.
Current Pharmaceutical Design
Title:Zein-Based Nanofibres for Drug Delivery: Classes and Current Applications
Volume: 21 Issue: 22
Author(s): Yong Zhang, Lili Cui, Yan Chen, Heng Zhang, Jian Zhong, Yanan Sun, Nianqiu Shi, Chunlei Li and Wei Kong
Affiliation:
Keywords: Biocompatibility, biomedical application, biopolymer, immunogenicity, zein.
Abstract: Plant proteins have been drawing increasing attention owing to their safety, abundance and relatively low cost in comparison with animal proteins. The development of plant protein-based delivery vehicles may lead to the provision of novel pharmaceutical products to patients. Zein is a class of alcohol-soluble prolamine proteins present in maize endosperm that was approved as a generally recognised as safe excipient in 1985 by the US FDA for use in pharmaceutical film coatings. Over the past few decades, numerous studies have been carried out to illustrate zein’s potential for novel applications in the biomedical field. This paper reviews the present status of zein-based nanofibres, with emphasis on their fabrication and biomedical applications, particularly for drug delivery. Their benefits and limitations are also discussed to provide further insight into zein’s potential as a promising biomaterial.
Export Options
About this article
Cite this article as:
Zhang Yong, Cui Lili, Chen Yan, Zhang Heng, Zhong Jian, Sun Yanan, Shi Nianqiu, Li Chunlei and Kong Wei, Zein-Based Nanofibres for Drug Delivery: Classes and Current Applications, Current Pharmaceutical Design 2015; 21 (22) . https://dx.doi.org/10.2174/1381612821666150531170448
DOI https://dx.doi.org/10.2174/1381612821666150531170448 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
RNA Interference-Based Gene Expression Strategies Aimed at Sustained Therapeutic Inhibition of HIV
Current Topics in Medicinal Chemistry Effects of Nicotine During Pregnancy: Human and Experimental Evidence
Current Neuropharmacology Recent Highlights in the Synthesis of Anti-HCV Ribonucleosides
Current Medicinal Chemistry Metabolic Basis of Polycystic Ovarian Syndrome; Indications for Biochemical Screening
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial [Hot Topic: Sepsis (Guest Editor: David E. Joyce)]
Current Drug Targets Experimental Drugs for Neuropathic Pain
Current Neuropharmacology Information Extraction in the Life Sciences: Perspectives for Medicinal Chemistry, Pharmacology and Toxicology
Current Topics in Medicinal Chemistry Regulation of Dendritic Cell Function Through Toll-Like Receptors
Current Molecular Medicine In Vitro Models for the Study of Non-Alcoholic Fatty Liver Disease
Current Medicinal Chemistry Synthesis of 2-Thiohydantoins as Somatostatin Subtype 4 Receptor Ligands
Letters in Drug Design & Discovery Muscle Atrophy Classification: The Need for a Pathway-Driven Approach
Current Pharmaceutical Design PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay
Current Drug Targets Combination Therapy in Fibromyalgia
Current Pharmaceutical Design The Multifunctional Protein p62 and Its Mechanistic Roles in Cancers
Current Cancer Drug Targets Patent Selections
Recent Patents on Regenerative Medicine BHUx: A Patented Polyherbal Formulation to Prevent Hyperlipidemia and Atherosclerosis
Recent Patents on Inflammation & Allergy Drug Discovery Topical Imiquimod: Mechanism of Action and Clinical Applications
Mini-Reviews in Medicinal Chemistry Novel Drug-Induced Pulmonary Complications in Cancer Patients You Can Save Life!
Current Respiratory Medicine Reviews Distinctive Cellular Roles for Novel Protein Kinase C Isoenzymes
Current Pharmaceutical Design Cerebral Palsy: Classification, Etiology and Evolution of Spine Deformity in Children and Adolescents
Current Pediatric Reviews